Home/Traverse Biotech/Bob Dufour, MBA
BD

Bob Dufour, MBA

Chief Business Officer

Traverse Biotech

Therapeutic Areas

Traverse Biotech Pipeline

DrugIndicationPhase
CD3 X ROR2 DuoBodyMultiple Oncology IndicationsPreclinical
Targeting Innate ImmunityOncology and AgingResearch